Rubicon Organics Inc (OTCPK:ROMJF)
$ 0.32 -0.0087 (-2.64%) Market Cap: 21.42 Mil Enterprise Value: 28.63 Mil PE Ratio: 0 PB Ratio: 0.73 GF Score: 50/100

Q1 2026 Rubicon Organics Inc Earnings Call Transcript

May 14, 2026 / 02:00PM GMT
Release Date Price: $0.3362 (-8.02%)

Key Points

Positve
  • Rubicon Organics Inc (ROMJF) achieved an 11% year-over-year revenue growth in Q1 2026, driven by strong performance in its 1964 brand.
  • The company maintained its position as Canada's number one premium licensed producer, with its 1964 Supply Co. brand representing two-thirds of net revenue.
  • Rubicon Organics Inc (ROMJF) successfully launched its 1964 brand in the UK, marking its first brand-forward entry into an international medical market.
  • The Cascadia facility's initial harvests showed promising results, with THC potencies comparable to the Pacifica facility, indicating potential for future growth.
  • The company has a clear strategy for margin expansion, focusing on processing automation, yield improvement, and dual facility scale efficiencies.
Negative
  • Gross margin before fair value adjustments decreased to 20% in Q1 2026 from 31% in Q1 2025, impacted by Cascadia's pre-revenue ramp-up costs.
  • Operating expenses increased by $1.6 million year-over-year due to planned investments in talent, brand development, and international initiatives.
  • Adjusted EBITDA was a loss of $580,000 in Q1 2026, compared to a positive $700,000 in Q1 2025, reflecting increased fixed cost infrastructure.
  • The BC distribution strike in late 2025 continued to impact revenue, with the premium flower market in BC down double digits year-over-year.
  • The company anticipates continued pricing pressure in international markets, which could affect margins despite the premium positioning.
Operator

Good morning, everyone. Welcome to Rubicon Organics' Q1 2026 earnings call for the three months ended March 31, 2026. As a reminder, this call is being recorded. (Operator Instructions) Before we begin, please refer to slide two for our caution regarding forward-looking statements and non-GAAP measures. Today's presenters are Margaret Brodie, CEO; and Glen Ibbott, CFO.

I'll now turn the call over to Margaret.

Margaret Brodie
Rubicon Organics Inc - Chief Executive Officer, Director

Good morning, everyone. Today, I'm providing an update on Rubicon Organics and our progress on 2026, the year we've described as a year of two halves. As previously outlined, 2026 is a transition year, with our new Cascadia facility ramping up and adding costs to the business in the first half as we complete the ramp up; where in the second half, we expect to meaningfully see the financial benefits.

In the first quarter of 2026, we saw revenue from our existing footprint, excluding Cascadia, grow 11% year over year. At the same time, our gross profit and bottom

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot